Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News HOOKIPA Pharma Inc HOOK

Healthcare Biotechnology
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HOOK)

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

GlobeNewswire 13 days ago

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers

GlobeNewswire April 24, 2024

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 16, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of HOOKIPA Pharma Inc. (HOOK) and Encourages Long-Term Investors to Contact the Firm

Newsfile April 15, 2024

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration

GlobeNewswire April 10, 2024

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

GlobeNewswire March 22, 2024

HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference

GlobeNewswire March 6, 2024

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs

GlobeNewswire January 29, 2024

HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization

GlobeNewswire January 16, 2024
View More News ››

Opinion & Analysis (NDAQ:HOOK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:HOOK)

HOOKIPA Pharma Announces FDA Clearance of its Investigationa

BREAKING NEWS: $HOOK HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of...
whytestocks - 13 days ago
View more Bullboard ››

Geologica Resource Corp.

Geologica Resource Corp.

Geologica Resource Corp. is an exploration and development company focused on the acquisition, exploration and development of ...
View More »